These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16330545)

  • 1. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells.
    Säfholm A; Leandersson K; Dejmek J; Nielsen CK; Villoutreix BO; Andersson T
    J Biol Chem; 2006 Feb; 281(5):2740-9. PubMed ID: 16330545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion.
    Dejmek J; Dib K; Jönsson M; Andersson T
    Int J Cancer; 2003 Jan; 103(3):344-51. PubMed ID: 12471617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells.
    Jönsson M; Andersson T
    J Cell Sci; 2001 Jun; 114(Pt 11):2043-53. PubMed ID: 11493640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells.
    Medrek C; Landberg G; Andersson T; Leandersson K
    J Biol Chem; 2009 Apr; 284(16):10968-79. PubMed ID: 19244247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
    Säfholm A; Tuomela J; Rosenkvist J; Dejmek J; Härkönen P; Andersson T
    Clin Cancer Res; 2008 Oct; 14(20):6556-63. PubMed ID: 18927296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
    Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2.
    Kamino M; Kishida M; Kibe T; Ikoma K; Iijima M; Hirano H; Tokudome M; Chen L; Koriyama C; Yamada K; Arita K; Kishida S
    Cancer Sci; 2011 Mar; 102(3):540-8. PubMed ID: 21205070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.
    Hansen C; Howlin J; Tengholm A; Dyachok O; Vogel WF; Nairn AC; Greengard P; Andersson T
    J Biol Chem; 2009 Oct; 284(40):27533-43. PubMed ID: 19651774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells.
    Prasad CP; Chaurasiya SK; Axelsson L; Andersson T
    Mol Oncol; 2013 Oct; 7(5):870-83. PubMed ID: 23727359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells.
    Leandersson K; Riesbeck K; Andersson T
    Nucleic Acids Res; 2006; 34(14):3988-99. PubMed ID: 16914445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.
    Kurayoshi M; Oue N; Yamamoto H; Kishida M; Inoue A; Asahara T; Yasui W; Kikuchi A
    Cancer Res; 2006 Nov; 66(21):10439-48. PubMed ID: 17079465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer.
    Ford CE; Ekström EJ; Howlin J; Andersson T
    Cell Cycle; 2009 Jun; 8(12):1838-42. PubMed ID: 19448401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1β stimulation of CCD-18co myofibroblasts enhances repair of epithelial monolayers through Wnt-5a.
    Raymond M; Marchbank T; Moyer MP; Playford RJ; Sanderson IR; Kruidenier L
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1270-8. PubMed ID: 22982339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
    Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.
    Kurayoshi M; Yamamoto H; Izumi S; Kikuchi A
    Biochem J; 2007 Mar; 402(3):515-23. PubMed ID: 17117926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT-5A: signaling and functions in health and disease.
    Kumawat K; Gosens R
    Cell Mol Life Sci; 2016 Feb; 73(3):567-87. PubMed ID: 26514730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
    Jönsson M; Dejmek J; Bendahl PO; Andersson T
    Cancer Res; 2002 Jan; 62(2):409-16. PubMed ID: 11809689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.
    Dejmek J; Säfholm A; Kamp Nielsen C; Andersson T; Leandersson K
    Mol Cell Biol; 2006 Aug; 26(16):6024-36. PubMed ID: 16880514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor.
    Huguet EL; Smith K; Bicknell R; Harris AL
    J Biol Chem; 1995 May; 270(21):12851-6. PubMed ID: 7759542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.